Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Gene and Protein Information ![]() |
||||||
| Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
| Human | 1 | 1032 | 3p21.2 | TLR9 | toll like receptor 9 | |
| Mouse | 1 | 1032 | 9 F1 | Tlr9 | toll-like receptor 9 | |
| Rat | - | - | 8 | Tlr9 | toll-like receptor 9 | |
Previous and Unofficial Names ![]() |
| CD289 | toll-like receptor 9 |
Database Links ![]() |
|
| Alphafold | Q9NR96 (Hs), Q9EQU3 (Mm) |
| CATH/Gene3D | 3.80.10.10, 3.40.50.10140 |
| ChEMBL Target | CHEMBL5804 (Hs), CHEMBL6128 (Mm) |
| DrugBank Target | Q9NR96 (Hs) |
| Ensembl Gene | ENSG00000239732 (Hs), ENSMUSG00000045322 (Mm), ENSRNOG00000048161 (Rn) |
| Entrez Gene | 54106 (Hs), 81897 (Mm), 338457 (Rn) |
| Human Protein Atlas | ENSG00000239732 (Hs) |
| KEGG Gene | hsa:54106 (Hs), mmu:81897 (Mm), rno:338457 (Rn) |
| OMIM | 605474 (Hs) |
| Pharos | Q9NR96 (Hs) |
| UniProtKB | Q9NR96 (Hs), Q9EQU3 (Mm) |
| Wikipedia | TLR9 (Hs) |
Download all structure-activity data for this target as a CSV file
| Agonists | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Antagonists | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
| Immunopharmacology Comments |
| TLR9 is an endosomal receptor detecting viral and bacterial CpG DNA and genomic DNA from some protozoan species [4]. Activated TLR9 receptors expressed by B cells and plasmacytoid dendritic cells, stimulate human B-cell proliferation, enhance antigen-specific antibody production and induce IFN-α production, IL-10 secretion and natural killer cell activity. |
Clinically-Relevant Mutations and Pathophysiology
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
| General Comments |
|
TLR9 is an intracellular detector for pathogen-derived nucleic acids, in particular CpG dinucleotides. Trafficking of endosomal TLR9 is tightly controlled to prevent inappropriate activation [2]. The potential role of TLR9 in immuno-oncology is reviewed in [1]. |
1. Adams JL, Smothers J, Srinivasan R, Hoos A. (2015) Big opportunities for small molecules in immuno-oncology. Nat Rev Drug Discov, 14 (9): 603-22. [PMID:26228631]
2. Babdor J, Descamps D, Adiko AC, Tohmé M, Maschalidi S, Evnouchidou I, Vasconcellos LR, De Luca M, Mauvais FX, Garfa-Traore M et al.. (2017) IRAP+ endosomes restrict TLR9 activation and signaling. Nat Immunol, 18 (5): 509-518. [PMID:28319098]
3. Lamphier M, Zheng W, Latz E, Spyvee M, Hansen H, Rose J, Genest M, Yang H, Shaffer C, Zhao Y et al.. (2014) Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo. Mol Pharmacol, 85 (3): 429-40. [PMID:24342772]
4. Uematsu S, Akira S. (2008) Toll-Like receptors (TLRs) and their ligands. Handb Exp Pharmacol, (183): 1-20. [PMID:18071652]
5. (2006) CpG 7909: PF 3512676, PF-3512676. Drugs R D, 7 (5): 312-6. [PMID:16922592]